InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
0
T+90 hit rate
100%
T+90 mean return
+2.2%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the full record of transactions filed by REYNO LEONARD, Chief Medical Officer. Insider active across 1 company, notably C4 Therapeutics, Inc.. Cumulatively, 6 disclosures have been published. Activity tracked since 10 July 2023. The latest transaction was filed on 10 July 2025 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.
Declarations6 total
15,325 shares0Common StockSEC:0001662579-25-000057:0
15,325 shares0Common StockSEC:0001662579-25-000057
87,100 shares0Common StockSEC:0001662579-25-000014:0
6,191 shares@ US$5.00100.0% of flowCommon StockSEC:0001662579-24-000066:0
36,700 shares0Common StockSEC:0001662579-24-000019:0
61,300 shares0Common StockSEC:0001662579-23-000074:0
6 of 6 declarations
About REYNO LEONARD
Leonard Reyno is the Chief Medical Officer of C4 Therapeutics, Inc. He is responsible for the medical direction of the company, including research and development of new treatments. His expertise in the medical field is essential for advancing C4 Therapeutics' goals.
